azithromycin 500 mg
Product Description
BIOGEN PHARMACEUTICAL CO.
-
Country/Region:India
-
On CPHI since:2022
Categories
Specifications
BIOGEN PHARMACEUTICAL CO.
-
Country/Region:India
-
On CPHI since:2022
BIOGEN PHARMACEUTICAL CO. resources (1)
-
News Biogen receives accelerated approval for first-of-its-kind ALS treatment
Biogen has announced that they have received approval from the US FDA for the amyotrophic lateral sclerosis (ALS) treatment, QALSODY™ (tofersen). This is the first approval of a treatment that targets a genetic cause of ALS.